NUZ 6.25% 22.5¢ neurizon therapeutics limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1241

  1. 2,738 Posts.
    lightbulb Created with Sketch. 1499
    So if it was that superficial surely it would have been easy for management to proactivley quell the negativity by explaining the whys of it? Instead the try to hide it in a quarterly. The market is doing what it does, retreat from risk and uncertainty.

    The decline in SP is not over reactive shareholders fault, it is piss poor leadership by PAA managment.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.